Associations between anterior cingulate cortex glutamate and γ-aminobutyric acid concentrations and the harm avoidance temperament

Neuroscience Letters

Volumn 464, Issue 2, 2009, Pages 103-107

  Kim, Hengjun J ^a   Kim, Jieun E ^b   Cho, Gyunggoo ^c   Song, In Chan ^b   Bae, Sujin ^a   Hong, Seokjun J ^a   Yoon, Sujung J ^d   Lyoo, In Kyoon ^a,b   Kim, Tae Suk ^d  

^a Seoul National University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea Basic Science Institute (KBSI)   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Aminobutyric acid; Anterior cingulate cortex; Glutamate; Harm avoidance; Magnetic resonance spectroscopy; Personality

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID;

4 AMINOBUTYRIC ACID BRAIN LEVEL; AMINO ACID BRAIN LEVEL; ARTICLE; CINGULATE GYRUS; FEMALE; FRONTAL LOBE; HUMAN; MALE; NEUROTRANSMISSION; PERSONALITY TEST; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERAMENT; TEMPERAMENT AND CHARACTER INVENTORY; WHITE MATTER;

ADULT; AVOIDANCE LEARNING; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; GYRUS CINGULI; HARM REDUCTION; HUMANS; MALE; TEMPERAMENT;

EID: 69549114977     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.087     Document Type: Article

References (49)

1. Abrams K.Y., Yune S.K., Kim S.J., Jeon H.J., Han S.J., Hwang J., Sung Y.H., Lee K.J., and Lyoo I.K. Trait and state aspects of harm avoidance and its implication for treatment in major depressive disorder, dysthymic disorder, and depressive personality disorder. Psychiatry Clin. Neurosci. 58 (2004) 240-248
2. Amorapanth P., LeDoux J.E., and Nader K. Different lateral amygdala outputs mediate reactions and actions elicited by a fear-arousing stimulus. Nat. Neurosci. 3 (2000) 74-79
3. Bannerman D.M., Deacon R.M., Brady S., Bruce A., Sprengel R., Seeburg P.H., and Rawlins J.N. A comparison of GluR-A-deficient and wild-type mice on a test battery assessing sensorimotor, affective, and cognitive behaviors. Behav. Neurosci. 118 (2004) 643-647
4. Bishop S., Duncan J., Brett M., and Lawrence A.D. Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli. Nat. Neurosci. 7 (2004) 184-188
5. Bissiere S., Plachta N., Hoyer D., McAllister K.H., Olpe H.R., Grace A.A., and Cryan J.F. The rostral anterior cingulate cortex modulates the efficiency of amygdala-dependent fear learning. Biol. Psychiatry 63 (2008) 821-831
6. Brandt C.A., Meller J., Keweloh L., Hoschel K., Staedt J., Munz D., and Stoppe G. Increased benzodiazepine receptor density in the prefrontal cortex in patients with panic disorder. J. Neural. Transm. 105 (1998) 1325-1333
7. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1 (1988) 623-634
8. Cloninger C.R. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr. Dev. 4 (1986) 167-226
9. Cloninger C.R. A systematic method for clinical description and classification of personality variants. A proposal. Arch. Gen. Psychiatry 44 (1987) 573-588
10. Cloninger C.R., Svrakic D.M., and Przybeck T.R. A psychobiological model of temperament and character. Arch. Gen. Psychiatry 50 (1993) 975-990
11. Conrad R., Wegener I., Imbierowicz K., Liedtke R., and Geiser F. Alexithymia, temperament and character as predictors of psychopathology in patients with major depression. Psychiatry Res. 165 (2009) 137-144
12. Crestani F., Lorez M., Baer K., Essrich C., Benke D., Laurent J.P., Belzung C., Fritschy J.M., Luscher B., and Mohler H. Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci. 2 (1999) 833-839
13. Cummings J.L. Anatomic and behavioral aspects of frontal-subcortical circuits. Ann. N. Y. Acad. Sci. 769 (1995) 1-13
14. Dunayevich E., Erickson J., Levine L., Landbloom R., Schoepp D.D., and Tollefson G.D. Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder. Neuropsychopharmacology 33 (2008) 1603-1610
15. Epperson C.N., O'Malley S., Czarkowski K.A., Gueorguieva R., Jatlow P., Sanacora G., Rothman D.L., Krystal J.H., and Mason G.F. Sex, GABA, and nicotine: the impact of smoking on cortical GABA levels across the menstrual cycle as measured with proton magnetic resonance spectroscopy. Biol. Psychiatry 57 (2005) 44-48
16. Farmer A., Mahmood A., Redman K., Harris T., Sadler S., and McGuffin P. A sib-pair study of the Temperament and Character Inventory scales in major depression. Arch. Gen. Psychiatry 60 (2003) 490-496
17. Farmer R.F., and Seeley J.R. Temperament and character predictors of depressed mood over a 4-year interval. Depress. Anxiety 26 (2009) 371-381
18. Faytout M., Tignol J., Swendsen J., Grabot D., Aouizerate B., and Lepine J.P. Social phobia, fear of negative evaluation and harm avoidance. Eur. Psychiatry 22 (2007) 75-79
19. Gallinat J., Kunz D., Lang U.E., Neu P., Kassim N., Kienast T., Seifert F., Schubert F., and Bajbouj M. Association between cerebral glutamate and human behaviour: the sensation seeking personality trait. Neuroimage 34 (2007) 671-678
20. 1H-magnetic resonance spectroscopy. Arch. Gen. Psychiatry 58 (2001) 556-561
21. Goodman W.K. Selecting pharmacotherapy for generalized anxiety disorder. J. Clin. Psychiatry 65 Suppl 13 (2004) 8-13
22. Grachev I.D., and Apkarian A.V. Chemical heterogeneity of the living human brain: a proton MR spectroscopy study on the effects of sex, age, and brain region. Neuroimage 11 (2000) 554-563
23. 1H-MRS study on the effects of sex, age, and brain region. Hum. Brain Mapp. 11 (2000) 261-272
24. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., and Drevets W.C. Reduced prefrontal glutamate/glutamine and γ-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry 64 (2007) 193-200
25. Izzo E., Auta J., Impagnatiello F., Pesold C., Guidotti A., and Costa E. Glutamic acid decarboxylase and glutamate receptor changes during tolerance and dependence to benzodiazepines. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 3483-3488
26. Jansen J.F., Backes W.H., Nicolay K., and Kooi M.E. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 240 (2006) 318-332
27. Mason G.F., Petrakis I.L., de Graaf R.A., Gueorguieva R., Guidone E., Coric V., Epperson C.N., Rothman D.L., and Krystal J.H. Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol. Psychiatry 59 (2006) 85-93
28. Matthews S.C., Simmons A.N., Lane S.D., and Paulus M.P. Selective activation of the nucleus accumbens during risk-taking decision making. Neuroreport 15 (2004) 2123-2127
29. McCourt W.F., Gurrera R.J., and Cutter H.S. Sensation seeking and novelty seeking. Are they the same?. J. Nerv. Ment. Dis. 181 (1993) 309-312
30. Meyerhoff D.J., and Durazzo T.C. Proton magnetic resonance spectroscopy in alcohol use disorders: a potential new endophenotype?. Alcohol Clin. Exp. Res. 32 (2008) 1146-1158
31. Most S.B., Chun M.M., Johnson M.R., and Kiehl K.A. Attentional modulation of the amygdala varies with personality. Neuroimage 31 (2006) 934-944
32. Nitschke J.B., Sarinopoulos I., Oathes D.J., Johnstone T., Whalen P.J., Davidson R.J., and Kalin N.H. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am. J. Psychiatry 166 (2009) 302-310
33. Olney J.W., de T., and Gubareff. Glutamate neurotoxicity and Huntington's chorea. Nature 271 (1978) 557-559
34. Perlov E., Philipsen A., Hesslinger B., Buechert M., Ahrendts J., Feige B., Bubl E., Hennig J., Ebert D., and Tebartz van L. Elst, Reduced cingulate glutamate/glutamine-to-creatine ratios in adult patients with attention deficit/hyperactivity disorder-a magnet resonance spectroscopy study. J. Psychiatr. Res. 41 (2007) 934-941
35. Pezawas L., Meyer-Lindenberg A., Drabant E.M., Verchinski B.A., Munoz K.E., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., and Weinberger D.R. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 8 (2005) 828-834
36. Phan K.L., Fitzgerald D.A., Cortese B.M., Seraji-Bozorgzad N., Tancer M.E., and Moore G.J. Anterior cingulate neurochemistry in social anxiety disorder: 1H-MRS at 4 Tesla. Neuroreport 16 (2005) 183-186
37. Pillay S.S., Gruber S.A., Rogowska J., Simpson N., and Yurgelun-Todd D.A. fMRI of fearful facial affect recognition in panic disorder: the cingulate gyrus-amygdala connection. J. Affect. Disord. 94 (2006) 173-181
38. Pollack M.H., Jensen J.E., Simon N.M., Kaufman R.E., and Renshaw P.F. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 739-743
39. Price R.B., Shungu D.C., Mao X., Nestadt P., Kelly C., Collins K.A., Murrough J.W., Charney D.S., and Mathew S.J. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol. Psychiatry 65 (2009) 792-800
40. Provencher S.W. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30 (1993) 672-679
41. Pujol J., Lopez A., Deus J., Cardoner N., Vallejo J., Capdevila A., and Paus T. Anatomical variability of the anterior cingulate gyrus and basic dimensions of human personality. Neuroimage 15 (2002) 847-855
42. Saudino K.J. Behavioral genetics and child temperament. J. Dev. Behav. Pediatr. 26 (2005) 214-223
43. Schubert F., Gallinat J., Seifert F., and Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage 21 (2004) 1762-1771
44. Stachowicz K., Klodzinska A., Palucha-Poniewiera A., Schann S., Neuville P., and Pilc A. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems. Neuropharmacology 57 (2009) 227-234
45. Sung S.M., Kim J.H., Yang E., Abrams K.Y., and Lyoo I.K. Reliability and validity of the Korean version of the Temperament and Character Inventory. Compr. Psychiatry 43 (2002) 235-243
46. Tao R., and Auerbach S.B. Regulation of serotonin release by GABA and excitatory amino acids. J. Psychopharmacol. 14 (2000) 100-113
47. Valenzuela M.J., Sachdev P.S., Wen W., Shnier R., Brodaty H., and Gillies D. Dual voxel proton magnetic resonance spectroscopy in the healthy elderly: subcortical-frontal axonal N-acetylaspartate levels are correlated with fluid cognitive abilities independent of structural brain changes. Neuroimage 12 (2000) 747-756
48. Vekovischeva O.Y., Aitta-aho T., Verbitskaya E., Sandnabba K., and Korpi E.R. Acute effects of AMPA-type glutamate receptor antagonists on intermale social behavior in two mouse lines bidirectionally selected for offensive aggression. Pharmacol. Biochem. Behav. 87 (2007) 241-249
49. Yoshino A., Kimura Y., Yoshida T., Takahashi Y., and Nomura S. Relationships between temperament dimensions in personality and unconscious emotional responses. Biol. Psychiatry 57 (2005) 1-6